Akkermansia Muciniphila Potentiates the Antitumor Efficacy of FOLFOX in Colon Cancer.
Ontology highlight
ABSTRACT: FOLFOX (oxaliplatin, fluorouracil and calcium folinate) is the first-line chemotherapy regimen for colon cancer therapy in the clinic. It provides superior efficacy than oxaliplatin alone, but the underlying mechanism remains unclear. In the present study, pharmacomicrobiomics integrated with metabolomics was conducted to uncover the role of the gut microbiome behind this. First, in vivo study demonstrated that FOLFOX exhibited better efficacy than oxaliplatin alone in colon cancer animal models. Second, 16S rDNA gene sequencing analysis showed that the abundance of Akkermansia muciniphila (A. muciniphila) remarkably increased in the FOLFOX treated individuals and positively correlated with the therapeutic effect. Third, further exploration confirmed A. muciniphila<
SUBMITTER: Hou X
PROVIDER: S-EPMC8484791 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA